Objective The metabolic influence of gut microbiota plays a pivotal role in the pathogenesis
of cardiometabolic diseases. Antibiotics affect intestinal bacterial diversity, and long-term …

Hypercholesterolemia is a major driver of atherosclerosis, thus contributing to high morbidity
and mortality worldwide. Gut microbiota have been identified as modulator of blood lipids …

Background and aims Host–microbiota interactions involving metabolic pathways have
been linked to the pathogenesis of atherosclerotic disease and type 2 diabetes. As stable …

The gut microbiota has been linked to cardiovascular diseases. However, the composition
and functional capacity of the gut microbiome in relation to cardiovascular diseases have not …

The gut microbiota is associated with cardiovascular diseases, including atherosclerosis.
However, the composition, functional capacity, and metabolites of the gut microbiome about …

Background Coronary artery disease (CAD) is associated with gut microbiota alterations in
different populations. Gut microbe-derived metabolites have been proposed as markers of …

Over the past few decades, the treatment of atherosclerotic cardiovascular disease has
mainly been through an LDL lowering strategy and treatments targeting other traditional risk …

Evidence from the literature keeps highlighting the impact of mutualistic bacterial
communities of the gut microbiota on human health. The gut microbita is a complex …

The discovery that gut-microbiota plays a profound role in human health has opened a new
avenue of basic and clinical research. Application of ecological approaches where the …

Thousands of microorganisms reside in the human gut, and extensive research has
demonstrated the crucial role of the gut microbiota in overall health and maintaining …